SCHEMBL7987002

SCHEMBL7987002

COc1cc(OC)c2c(c1)nc(Nc1c(C)cccc1Cl)c1cncn12

nearest known ligand 0.79

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LCK P06239 19/20 0.79
SRC P12931 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984633 0.90 LCK (0.63) LCK
SCHEMBL7981217 0.88 LCK (1.00) LCK
SCHEMBL7980622 0.85 LCK (1.00) LCK
SCHEMBL7970084 0.84 LCK (1.00) LCK
SCHEMBL7981602 0.83 LCK (1.00) LCKSRC
SCHEMBL7983469 0.81 LCK (0.85) LCK
SCHEMBL7969699 0.80 LCK (0.85) LCKSRC
SCHEMBL7983567 0.79 LCK (0.79) LCK
SCHEMBL7981335 0.79 LCK (1.00) LCK
SCHEMBL7969634 0.79 LCK (0.88) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed